Jiangsu Hansoh Pharma Now Said To Plan $3 Billion IPO
Published: Jan 07, 2016
According to The Wall Street Journal, Jiangsu Hansoh Pharma is planning to raise over $3 billion in an IPO on the Hong Kong market, which would be record amount for a pharma IPO in Hong Kong. One month ago, it was reported that Hansoh would seek $1.5 billion in an initial offering, implying that the reports are partly rumor. The company may complete a filing for the transaction as early as March, which will shed more light on Hansoh and its IPO. The actual transaction is scheduled for Q3 of this year.